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HIV is currently ranked among the leading causes of death in Kenya and in the world, with an 
estimated 1.5 Million Kenyans living with HIV and 28,000 deaths recorded annually as a result of 
AIDS related illnesses. In 2014, UNAIDS launched a 90-90-90 strategy the aim was to diagnose 
90 per cent of all HIV- positive persons, provide antiretroviral therapy (ART) for 90 percent of 
those diagnosed, and achieve viral suppression for 90 per cent of those treated by 2020. 
This study is motivated by the need to assess the 3rd 90; viral suppression for 90 per cent of those 
ART treated and seeks to analyze one statistical paradigm (Bayesian) that have conventionally 
been used for geospatial trends. Use of Bayesian approach has been used previously to assess 
the prevalence and incidence of diseases however, this dissertation seeks to evaluate Bayesian 
Approach to spatial trends of HIV Viral Load Suppression in Kenya. We revisit the theoretical 
framework of the Bayesian Approach and apply real data from the Kenyan setting spanning from 
2012 to 2017. 
Results show Bayesian Approach to be robust, in depth and entails more information when 
modelling spatio-trends of Viral Load suppression. Further, First Line ART regimen, HIV-TB 
co-infection and retention rates are significant predictors of Viral Load suppression spread. 
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This chapter is a discussion on the HIV trends and statistics from a global perspective as well as 
a Kenyan setting. 
It also shows the gaps that this study seeks to address; as well as the research objectives; the 
scope and the significance of this study. 
1.1 Background Information 
In 2014, United Nations Program on HIV/AIDS (UNAIDS) launched the 90-90-90 target goals 
whose aim was to achieve 90 per cent suppression among the HIV infected persons , to ensure 
that 90 per cent of the HIV infected people are under ARV treatment, and ensure that 90 per cent 
of all HIV infected persons have been diagnosed and are therefore aware of their status by 2020 
as per (Levi et al., 2016). 
Globally; an estimated 36.7 million people are living with HIV, of which 2.1 million are children. 
This translates to 1.8 million new infections each year (approximately 5000 new infections daily), 
of which about 160,000 are children below the age of 15 years as shown by (Sidibe et al., 2016). 
In terms of prevalence; Swaziland is currently leading with 27.2 per cent, but the numbers are 
especially high in South Africa, where about 7.1 Million people are living with HIV and 3.2 million 
in Nigeria, that is 18.9 per cent and 2.9 per cent prevalence respectively (Cheluget et al., 2006). 
It is estimated that about 1.5 million Kenyans were living with HIV in 2016 as per a report done by 
(Sidibe et al., 2016) whereas an estimated 71 ,034 new infections were recorded among adults 
(Age 15+), and 6,613 new infections recorded among children (Ages 0-14) in that same year. 
This translates to a prevalence rate of about 7 per cent for women, who are most vulnerable to 
HIV infections and 4.7 per cent for men, with the most affected county being Homabay County; 
whose prevalence is 26 per cent. HIV therefore contributes to 29 per cent of annual adult deaths, 
20 per cent of maternal mortality and 15 per cent of deaths of children under the age of five years. 
This simply means, for every 100 adult deaths, 29 of them are due to AIDS related illnesses. 
Treatments for HIV involves a combination of different drugs, which is the ARVs-T, which prevents 
the virus from replicating; maintaining the immunity levels of the person while slowly reducing the 
progression of the virus in the body. According to a study done on GMSM in Australia in 2012, 50-
70 per cent of people diagnosed with HIV and were receiving treatment through administration 
of ARV-T; 85-95 per cent had a suppressed viral load (Nicole et al., 2015). Viral suppression 
rates have also been found to be low among children on ART in LMICs; even after continuous 
ART administration and periodic monitoring of the same a reported by (Boerma R and J, 2016). 
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According to another report conducted in the USA, 85 per cent of the people diagnosed with HIV; 
49 per cent of them had the virus under control through ART (CDC, 2005). 
Administration of ARV reduces the viral load content per millimeter of blood suppressing the 
virus, hence slowing down progression of HIV to AIDS (lckovics and Meade, 2002) and this can 
prevent transmission of the HIV virus to uninfected partners (Cohen et al., 2011 ). Since HIV virus 
attacks the immune system cell in the body, known as CD4 helper lymphocyte cells, making the 
body unable to fight other infections; administration of ART will almost successfully suppress the 
virus, reducing it to a certain level even undetectable. Once the CD4 cell count falls below 200 
cells/mm3, HIV is said to have progressed to AIDs. 
Studying retention in HIV care improves survival and HIV Viral control and decreases race or 
ethnicity related healthcare disparities (Tobias et al., 2007) and is an important indicator for quality 
of healthcare services (Braitstein et al., 201 0). Its is however estimated that only 75 per cent of 
HIV-diagnosed patients are linked to care and only 66 per cent of them are retained in care 
successfully in the United States( Gardner et al., 2011 ). In Kenya, 64 per cent of adults were on 
ART as compared to 65 per cent of children in 2016 (UNAIDS, 2017) 
In 2015,81 per cent of people initiated on treatment were still in care after 12 months, which is an 
improvement on the 2013 retention rate which was 70 per cent (NACC, 2016) 
This study will therefore aim at finding out the suppression rates among children and adults and 
also establish the percentages of this population who have the virus under control due to the 
administration of the ART. This study will also show the trends in the suppression rates while 
trying to model the same for future use. 
1.2 Problem Statement 
HIV is a continued concern for many governments. Reduction of new annual infections will reduce 
the HIV prevalence rates in the country. 
Periodic monitoring of the viral loads among the infected assists in proper administration of ART 
as well as prevent transmission of HIV from mother to infant during birth or maternal care and 
even between partners. 
To establish how well the ART is working among demographic population; there is need for us to 
examine the suppression rates and patterns of the HIV virus among demographic population, the 
children and the adults as well as model these trends; to have a better understanding of how the 
ART is working in that demographic group. 
High suppression rates may indicate that the patients are keen to follow the prescribed dosages 
for the ART while the opposite will also be true. 
Whereas GIS has been used to model epidemic spread of diseases no attempt has been made 
to extend its application in critical disease programming and monitoring, specially in viral load 
monitoring in HIV/AIDS. 
1.3 Research Objective 
The aim of this study is to model distributions and patterns of viral load suppression using Ge-
ographic Information Systems as well as use of Bayesian Statistics to model outcomes of Viral 
Load suppression. 
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1.3.1 Specific Objective 1 
To conduct location analysis by focusing on Viral Load analysis 
1.3.2 Specific Objective 2 
To conduct analysis of Viral Load patterns and HIV predictors with intention of analyzing health 
complexities. 
1.4 Scope of the Study 
This study analysed trends and patterns in HIV viral suppression rates and HIV retention among 
demographic population in the 47 counties of Kenya through use of GIS from Jan 2012 to De-
cember 2017. 
1.5 Significance of the Study 
This study will assist the government in decision making on distribution of resources to areas with 
least suppression rates. 
This study will also be beneficial to the National Aids and Control Council (NACC)who are cur-
rently mandated with the task of reducing HIV prevalence rates in the country through education, 
training and awareness, and rigorous administration of ARVs-T and to achieve World Health Or-
ganization ambitious target of achieving 90 per cent viral suppression for HIV patients on ARV-T. 
Globally; this research will assist in continuous improvement of Antiretroviral Therapy; given the 




This chapter provides discussions on HIV trends, prevalence, and viral suppression rates both 
globally and locally, as well as new developments in HIV. 
2.1 HIV Trends and Statistics 
2.1.1 A global look on the trends and statistics 
Overall, an estimated 36.9 million people were living with HIV at the end of 2017. Among these 
people, 1.8 million are children. Majority of these people live in sub-Saharan Africa. 19.4 million 
are people living in East and Southern Africa, 6.1 Million are living in western and central Africa, 
5.1 Million live in Asia, 2.1 are living in West and Central Europe and North America, another 2.1 
live in Latin America and the Caribbean, 1.6 Million are in East Europe and Central Asia, while 
only 230,000 people are in the middle east and North Africa (Sidibe et al., 2016). 
In terms of mortality, 940,000.00 died of HIV related illnesses worldwide, while 1.8 million people 
became newly infected, in 2017. Since the start of the epidemic, 77.3 million have become 
infected; while 35.4 million have died due to AIDs related illnesses (Sidibe et al., 2016). This is a 
reduction in AIDs related illnesses by 51 per cent since 2004, while the number of new infections 
declined by about 16 per cent among adults and 35 per cent among children since 2010. 
Over time, disease monitoring indicators of HIV have changed from CD4 count to Viral load. Viral 
load measures the amount of virus per milimeter of blood. In order to measure progress, there is 
need to monitor VL in PLWHIV and assess the effectiveness of the ART-T to them. 
2.1.2 Trends and statistics in Kenya 
In Kenya,an estimated 1.6 million people are living with HIV. According to a report released in 
2017, 36,000 people died from AIDS-related illnesses in 2016. Kenya's HIV epidemic is gener-
alized, and therefore affects all groups of people,from children, young adults, men and women 
alike. (Sidibe et al., 2016) 
Groups most affected by HIV are sex workers, who have the highest prevalence (NACC, 2016) 
at 29.3 per cent prevalence. Prevalence among men who have sex with other men is at 18.2 
per cent, while People Who Inject Drugs are estimated to be 18.3 per cent were living with 
HIV. Further; its estimated, that young women are more likely to acquire HIV than their male 
counterparts,and accounted for 33 per cent of all new infections, as compared to 16 per cent of 
new infections in men (NACC, 2016). The young adults are more vulnerable to new infections due 
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to factors such as incorrect perception of the risk on exposure, forced sex and sexual violence 
among others. 
In Kenya, measurement of VL is a great way of monitoring progress in the HIV epidemic, as well 
as assessment of retention and therefore adherence. Over the years, the prevalence rates may 
have declined but there is need to assess the progress given the 90-90-90 targets by UNAIDS 
and WHO (Levi et al., 2016). 
2.2 Access to treatment- Global and group perspectives 
Continuous education and HIV awareness has greatly increased knowledge of HIV in schools, as 
it forms part of the curriculum in all schools. Mother to Child Transmission has also been greatly 
reduced. Number of newly infected children fell from 12,000 to 6,600 in 2015, attributed majorly 
to PMTCT services (UNAIDS, 2017). 
It is estimated that 64 per cent of adults and 65 per cent of children were accessing ART in 2016 
as a result of increased HIV awareness. 
In 2015, 81 per cent of people on treatment, of whom 64 per cent were virally suppressed, which 
equates to 51 per cent of all people in Kenya living with HIV (UNAIDS, 2017). 
HIV is a leading cause of death among young adults,mostly because most young people will 
find it difficult to adhere to treatment, leading to a form of drug resistance, making H IV treatment 
options more limited with time (Onywera et al., 2017). 
A 2015 report by the World Health Organization estimates global coverage on ART-T to be 46 
per cent, this is estimated to be 17 million people. The report attributed the major increase to 
coverage in Africa regions where coverage increased from 24 per cent in 2010 to 54 per cent in 
2015. 
Global coverage of ART-T is a good indicator of having HIV under control, however, the expected 
target should be 90 per cent and therefore more need to monitor progress of the disease. 
2.3 Suppression rates among demographic population 
Increasing viral suppression to a low or undetectable level improves the health of of those living 
with HIV and prevent sexual transmission of HIV to partners (Doshi et al., 2017). 
In 2014, 57.9 per cent of people living in the US were virally suppressed from 54.7 per cent in 
2013. Among the youth, 48.1 percent were vi rally suppressed, while 50.3 percent of PWID were 
also virally suppressed (Doshi et al., 2017). 
In Kenya, the national viral load monitoring program is used to monitor viral load across the coun-
try, with over 2,000 facilities currently, and over 40,000 tests conducted each month. According to 
NASCOP,there are 871,156 suppressed patients while 137,452 are not suppressed, this is 86.4 
per cent as compared to 13.6 per cent respectively. 
The national viral load monitoring program monitors VL suppression,however, there may be other 
indicators of VL suppression such as retention in care and therefore adherence,availability of 
donor funding to specific areas,HIV co-infections such as TB, Treatment level Regimens(whether 
1st Line or 2nd or 3rd Line) and many more. 
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2.4 Use of Geographical Information Systems in Disease Map-
ping 
GIS has been used extensively in epidemiology for disease surveillance and intervention monitor-
ing. Through mapping, governments have been able to identify disease spread and monitoring of 
the same, leading to proper control of epidemics such as trypanosomiasis in Africa (Clarke et al., 
1996). 
GIS was particularly used for planning HIV prevention interventions for High Risk Youth, whereby 
the information was used to map neigbourhoods where the youths were at highest risk of HIV/AIDS 
contraction and thereafter helped in decision making (Geanuracos et al., 2007). 
GIS was also used to map HIV in India, to help have a perspective of the disease spread and 
monitoring (Kandwal et al., 2009) 
GIS was also used to show the spatial spread of the AIDS epidemic in Ohio (Caselli and Fan, 
1991 ). 
GIS however, has not been extensively used in the area of disease programming and disease 
monitoring indicators for HIV which is the objective of this study. 
2.5 New developments in HIV Treatment 
There has been new developments in HIV recently especially in treatment of HIV and preven-
tion such as HIV vaccines whose research is currently ongoing, with good progress being made, 
however, great challenges still remain on the same, such as a new animal model data that indi-
cates that the viral reservoir is seeded before plasma virus becomes detectable in acute infection, 
(Sidibe et al., 2016) hence showing the vaccine might not be as effective as anticipated. 
There are other developments as well on developing the cure for HIV with several methods being 
modelled and developed as outlined by Clara Fernandez of Labiotech. 
These methods include, Stopping the replication of HIV, a method used to also treat herpes, 
Shock and Kill, which generally targets the hidden HIV reservoir that contains the inactive viruses 
that are waiting to be active and replicate, Immunotherapy, where the immune cells are super-
charged and strengthened to be able to attack the virus itself and lastly gene therapy, which is 
a method that currently seeks to edit the DNA of a person and introduce a mutation to stop HIV. 
This is because, an estimated 1 per cent of the world is naturally immune to HIV. 
2.6 Conclusion 
Geographic Information Systems have not been extensively used in the area of disease program-
ming for HIV and has only been used to map diseases and show spread of outbreaks but has 
not been used to show certain aspects of diseases such as retention, viral load monitoring and 
such other aspects useful in disease monitoring hence the gap that has been looked at in the 
study. Further, no attempt has been made to use bayesian approaches on such disease monitor-




This chapter contains the methods that were used to achieve the outcomes of interest in this 
study. 
3.1 Study Design 
Spatial analysis was used in this study. The study population involved all HIV positive patients 
who were actively on ART from 2014 to 2017 as per NASCOP VL website (http://viralload.nascop.org/). 
Participating sites included all facilities registered by government of Kenya with MFL(Master Fa-
cility List) codes. Abstracted data was assembled into a uniform excel format disaggregated by 
counties. The viral load data consisted of 3123 sites that treated HIV adult and pediatric patients. 
The data collected also included other variables i.e. testing month, redrawn samples, 1st line 
patients, patients with HIV!TB co-infection and retention rate from January, 2014 to December, 
2017 were extracted from the data warehouse. 
Areas of interest were as listed below; 
1. Current suppression rates in Kenya, in the different counties in Kenya. 
2. Current Retention rates in Kenya, at county level. 
3. Is there any correlation between retention and suppression rates. 
4. Is there any relationship between Patients on first line treatment, HIV-TB co-infection rates 
and VL suppression rates. 
5. Reason for low/high suppression rates and retention rates 
6. Comparison of the current suppression rates as compared to the expected rates of sup-
pression. 
3.2 Study Area and Data Collection 
The study area was the 47 different counties in Kenya. Data was obtained from health centers at 
a county level which comprised of data including viral load tests, viral load results with > 1 ,000 
mUcopies were collected retrospectively, by electronic abstraction from each site. Abstracted 
data were sent in electronic excel format to a Masterfile. 
Electronic data received was reviewed to ensure that each data element was correctly formatted 
and that all elements were captured. Data elements with incorrect formatting, unknown or incom-
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plete information, or other inaccuracies were reviewed with the site and corrected. The data was 
combined across sites to achieve a uniformly constructed multi-site database. 
3.3 Statistical Analysis 
Data was examined for viral load tested for patients on ART and virologic results were used to 
determine VL suppression. The primary area of interest was to analyze patterns of viral load 
suppression over the years. Given that the study sample is drawn from all facilities providing 
clinical care, individuals who were being initiated ART are likely to have VL test together with 
those already on ART. 
The data also included information on retention rates, HIV-TB Co-infection rates, as well as Num-
ber of patients on 1st line treatment and was used to examine whether there was any relationship 
between the same. Comparisons of hazards in non-referent categories were performed with lin-
ear combinations. For each interaction,effects of enrollment year on the hazard within categories 
of the other variables were assessed. To interpret interactions, we estimated the linear year trend 
(slope) of the hazard within categories of the other variable. Cumulative incidence curves were 
generated to display the cumulative incidence of ART initiation and virologic suppression prior to 
the competing risks by enrollment year. 
A non-parametric cumulative incidence function was used to estimate cumulative incidence in a 
competing risk situation. Cuzick's test was used for non-parametric trends . Statistical analysis 
was performed using R Studio version 3.5.3. 
3.4 Data Exploration and Visualization 
Data Exploration and Visualization involved getting a summary of the variables that were of inter-
est in order to scrutinize the patterns that emerged. 
The data contained 10 variables. The variables were basically, County, No. of Facilities Sending 
Samples, Rejected Samples, Redrawn Tests, Tests, Results with VL > 1 OOO,Patients on 1st Line 
treatment,Retention Rates, Patients with HIV-TB Co-infection and Year in which these samples 
were obtained. 
An additional variable which was of interest was obtained by subtracting the Results with VL > 
1000 from the total Tests obtained and then finding a percentage of the same so as to obtain the 
variable of individuals who were vi rally suppressed but as a percentage. This was done for each 
county and then done for each year from 2012 to 2017. 
Choropleth maps which show information by coloring each component area with color, providing 
an indication of the magnitude of the variable of interest which were then used as a means for 
visualizing this data over the same period of time. 
3.5 Relative Risk Estimation 
The data was from the 47 counties. Total Number of Tests taken were used interchangeably to 
denote the total population of that region. 
Let N;, denote the total number of samples taken in region i and let Y;, denote the observed 
number of suppressed cases in region i. The total number of tests taken in region i is given by 
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(3.1) 
The total number of cases of people who are suppressed in region i is given by 
(3.2) 
The total number of cases in the population is given by 
(3.3) 
Hence the expected number of cases in region i is given by 
(3.4) 
The Standard Morbidity Ratio(SMR)(Waller and Gotway, 2004) is a ratio obtained to show an es-
timate of the risk and is obtained by comparing the observed number of cases with the expected 
number of cases while mapping a disease in an area. This ratio will be obtained in this study 
and used in this study to show the number of expected virally suppressed population and the 
observed cases. The ratio is given by the below; 
SMR= i· (3.5) 
Values greater than one imply a suppression rate of HIV is higher than expected, while below 
one indicate a rate lower than expected for the respective area. However, a low value of Ei can 
happen if the population of a certain place is too low or if the disease under study is rare.To 
overcome this problem, Bayesian hierarchical spatial models are adopted. The study embraced 
use of the Bayesian Approach. 
3.6 Moran's Index Statistic 
Moran's I (Moran, 1950) is used to test the hypodissertation that there is no spatial autocorrelation 
in the outcome variable. II measures the overall spatial autocorrelation that exist in the data under 
study. High Moran's Index will indicate that the data is highly correlated while the opposite is also 
true. The expected value of Moran's I is -1/(N -1). Values of Moran's I that exceed -1/(N -1) 
indicate positive spatial autocorrelation, in which similar values, either high values or low values 
are spatially clustered. 
Values of I below -1/(N- 1) indicate negative spatial autocorrelation, in which neighboring 
values are not similar.(Li et al., 2007) 
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3. 7 Bayesian Approach 
The study used Conditional Autoregressive Methods in this approach.CAR models propose con-
ditionally autoregressive priors (CAR priors) in an empirical Bayes setting instead of the joint 
prior distribution.ln addition, Breslow and Clayton (Breslow and Clayton, 1993)apply CAR pri-
ors as random effects distributions within likelihood approximations for Generalized Linear Mixed 
Models. CAR models have a specified conditional mean and variance as shown below; 
E[Y(S;)I¥_;] = X(S;)'{J + E_f=1cij[Y(SJ)- X(S;)'{J]. (3.6) 
Var[Y(S;)IY-;] = 8;, i = 1, ... , N. (3.7) 
where the e;1 denote spatial dependence parameters. The primary purpose of CAR models is to 
provide a modelling mechanism to account for residual spatial correlation not explained by spatial 
patterns in covariate values. A number of different conditional autoregressive prior models have 
been proposed in a disease mapping context and in this case disease monitoring indicators 
context as below; 
1. Intrinsic Model. 
This is one of the simplest CAR model which was proposed by (Besag and Higdon, 1999) 
and (Besag et al., 1991) 
It has full conditional distributions given by; 
(3.8) 
This equation is interpreted as follows; The conditional expectation of rPk is equal to the 
mean of the random effects in neighbouring areas, while the conditional variance is in-
versely proportional to the number of neighbours nk. 
This variance structure recognises the fact that in the presence of strong spatial correlation, 
the more neighbours an area has the more information there is in the data about the value 
of its random effect. 
The advantage of this model is that it is simple and easy to apply but the downside is 
that the single parameter does not determine the strength of the spatial structure, and will 
therefore not accomodate weak correlations and as a result is rather restrictive. 
2. Convolution Model. 
This model combines intrinsic model but adds a set of random variables to the model and 
was proposed by Besag (Besag et al., 1991) 
The model is given by; 
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The downside of this model is that estimating the individual components ¢>k, '1/Jk is not al-
ways possible. The MCMC convergence is also slow for this model. 
3. Cressie Model. 
This model was proposed by Cressie (Cressie, 1992) and Stern H and Cressie (Stern 
and Cressie, 2000) This model is good because it helps determine the varying strengths of 
spatial correlations. This model uses a single set of random effects but introduces additional 
spatial correlation parameters. The model is given by; 
(3.1 0) 
This CAR prior has the same conditional variance as the intrinsic model, while the condi-
tional expectation is a weighted average of the mean of the random effects in neighbouring 
areas and an overall mean J.t. 
Here;the weight parameter p controls the strength of the spatial correlation between the 
random effects, with p=O corresponding to independence, while increasing its value towards 
one corresponds to increasingly strong spatial correlation (p=1 simplifies to the intrinsic 
model). 
The downside of this model is the form of the conditional variance, which is unappealing 
when p is close to zero. This is because in the absence of spatial correlation (when p=O) 
there is no reason for the conditional variance of rPk to be inversely proportional to the 
number of neighbours, as they provide no information about rPk 
4. Leroux Model. 
This model was introduced by Leroux (Leroux et al., 2000) and further explained by Mad nab 
(MacNab, 2003) (MacNab et al., 2006). This model is based on a single set of random ef-
fects¢>= (¢1, ...... , rl>n) which are represented by the multivariate Gaussian distribution. 
The conditional expectation is a weighted average of the random effects in neighbouring 
areas and the overall mean J.t, while the conditional variance has a more attractive form 
than that in Cressie Model. 
This model is better compared to Cressie because there is no longer any information about 
rPk in the neighbouring random effects. 
3.8 Summary Statistics 
In this approach unlike the Bayesian approach where we have CAR priors, we will make use of 
the data only and thereafter map it to find the results. 
We analysed the data and came up with an additional variable on "persons who are non sup-
pressed" and later used the additional variable to map the data to the counties which were used 
as the reference. 
Chloropleth (maps that are shaded with different color intensities)were then used to show the VL 
suppression spread across all the counties in the Country. 
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Chapter Four 
Results and Findings 
4.1 HIV Viral Load Cases 
The 2012 to 2017 data on viral load suppression increased gradually over time from 116 centres 
to 2122 centres in 2017 submitting information on viral load. This means that the number of 
people also being tested increased over time. 
Samples sent in, that were virally suppressed also increased over time significantly as shown 
below, as well as the number of tests that were taken over the years. The number of samples 
taken do not necessarily equal the number of people who visited the clinical facilities as one 
individual may have walked into the facility many times in that particular year or may have visited 
another clinic over the years. Suppression trends and outcomes are illustrated below as shown 
on NASCOP website till to date. The graphs indicate that more people are virally suppressed 
with time as compared to earlier years. 
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Figure 4.1: Figure showing sup-
pression trends:2012-2019 Source: 
NASCOP 
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Figure 4.2: Figure showing Suppres-
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The table below is a summary of the variables used, inform of their mean,lower and upper bound 
means. 
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Table 4.1: Table Showing a Summary Description of the Variables in the Data used in the study 
Variable Name Descriptive 2012 2013 2014 2015 2016 2017 
No.of.Facilities Mean 2.47 6.38 14.83 31.70 39.74 45.15 
Lower bound 1.47 8.61 17.29 41.58 51.31 57.69 
Upper Bound 3.46 8.61 19.05 41.58 51.31 57.69 
Rejected Samples Mean 3.21 20.68 39.88 81.64 91.11 156.04 
Lower bound 1.55 10.41 26.52 52.71 54.78 59.16 
Upper Bound 4.87 30.95 53.25 110.56 127.43 252.93 
Tests Redrawn Mean 4.34 22.74 129.36 299.45 520.45 325.13 
Lower bound 1.32 8.95 65.29 113.77 279.63 154.46 
Upper Bound 7.36 36.54 193.42 485.12 761.26 495.80 
Tests Taken Mean 872.87 3115.11 19243.19 51565.15 72775.45 88253.38 
Lower bound 475.98 1817.39 10971.73 30807.01 42026.41 52789.86 
Upper Bound 1269.76 4412.82 27514.65 72323.29 103524.49 123716.90 
Perc.VL non.supp Mean 43.05 46.48 25.32 19.99 19.69 20.09 
Lower bound 36.07 41.49 22.69 18.33 18.01 18.19 
Upper Bound 50.03 51.48 27.93 21.66 21.38 21.98 
1st Line Patients Mean 727 727 2818.67 14910.4 43207.12 62888.72 
Upper bound 392 392 1721.39 8080.49 25858.02 365535.44 
Lower Bound 1062 1062 3915.94 21740.32 60556.24 89242.01 
HIV-TB Coinfection Mean 261.26 261.26 826.69 4081.62 11233.85 16989.15 
Lower bound 152.36 152.36 511.32 2263.96 6723.08 10074.18 
Upper Bound 370.15 370.15 1142.06 5899.27 15744.62 23904.12 
Retention Perc Mean 46.61 46.61 75.42 71.54 75.45 90.13 
Lower bound 39.07 39.07 74.65 68.45 73.25 89.25 
Upper Bound 54.15 54.15 76.19 74.62 77.66 91.00 
VL>1000 Mean 431.79 1357.09 3841.12 8912.30 12594.60 14938.34 
Lower bound 253.4 883.16 2453.70 5580.29 7552.06 9357.66 
Upper Bound 610.17 1831.01 5228.54 12244.31 17637.13 20519.02 
Data visualization was done through use of box plots. Box plots are ideal in showing the median 
as well as the variability of the data, in this case the variables, over the period of time that they 
were collected. The box plot below shows the number of facilities that sent VL samples over 
between 2012 and 2017, which showed an increase of the same. 2012, few facilities may have 
been equipped as compared to 2017 hence the steady increase. 
Further, 2015-2017 numbers had more outliers, indicating that the data, showing the general 
variability of the data. 
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Figure 4.5: Trend Line that shows the number of sam-
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The box plot below shows the number of samples that were suppressed. These were samples 
which had VL with less than 1 OOOcopies/ml of blood. The box plot shows that the same increased 
steadily over the period. However, since the number of tests taken also increased over the 
period,further study in the numbers was needful. 
Figure 4.6: Box Plot showing the number of samples that 
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4.2 Results: Viral Load Suppression 












By examining the data at county level, and plotting non-suppression rates, this is what we found. 
In 2012, the counties that had highest number of virally non-suppressed persons were, Nyan-
darua, 
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Kakamega, Vihiga, Kajiado and Transzoia Counties. These counties also had the highest re-
tention rates in that same year. However, in terms in HIV-TB co-infection, Nairobi, Kericho, 
Machakos, 
Kisumu, Homa Bay had highest numbers of infected individuals as well as highest numbers of 
Patients on 1st Line were from these counties. Further, very few facilities were sending samples 
on Viral Load across the country, which were only 116. This is because Viral Load measurement 
had just been introduced as initially CD4 count was what was being used. In that same year, 
counties such as Lamu, West Pokot, Mandera, Tana River and lsiolo did not have any facility that 
monitored viral load to patients and therefore there were no records of any virally suppressed 
samples or any samples whatsoever. 
In 2013, there were some changes in counties which were least suppressed with Nyamira being 
at the top as well as Meru, Vihiga, Kakamega, lsiolo while counties such as Kisumu and Busia 
had high rates of viral suppression. However, Mandera, Wajir and Samburu still had no entries 
on VL. Most patients on 1st Line were from Kiambu, Kisumu, Uasin Gishu, Busia and Nairobi 
and the same counties topped in the number of patients with HIV-TB co-infection. In terms of 
retention, counties such as West Pokot, Uasin Gishu, Mombasa, Tharaka Nithi and Kisii had the 
most numbers in terms of retention. There was also an increase in facilities that measured the 
VL from 116 in 2012 to 300 centres in 2013. This must have been due to awareness created 
steadily over the period.Donor funding is said to have increased as well in that same period from 
18.85 per cent in 2012 to 19.6 per cent in 2013.(Kates et al., 2014) 
In 2014, 626 centers sent samples on VL, while counties such as Turkana, Mandera, Tharaka 
Nithi, Wajir and Samburu were the least virally suppressed as compared to Kiambu, Vihiga, Bu-
sia, Migori and Kwale whose suppression rates were high. Facilities sending samples increased 
as well, owing to more awareness and availability of funds in these areas. Lamu, however, did 
not send any samples on VL that year as well, as opposed to the previous year, 2013.This incon-
sistency may have been due to little awareness on the importance of VL monitoring or even due 
to poor facilities. 
In 2015,we observed that the facilities sending the samples grew to 1490, as compared to 626 
centres in 2014. Counties such as Baringo, Wajir, Samburu, Turkana and Mandera were least 
suppressed. Populations in these counties is low as compared to other counties, and may there-
fore not necessarily mean that these counties were doing poorly. However,counties such as 
Kiambu, Nairobi, Nyeri, Kirinyaga and Meru had high number of suppression rates, meaning that 
most samples sent had VL of less than 1 OOOcopies/ml of blood. Further,Migori, Siaya, Homabay, 
Kisumu and Nairobi counties had the highest number of individuals with HIV-TB co-infections as 
well as patients on 1st Line Treatment. High retention rates were observed in Meru, Kirinyaga, 
Nyeri,Nairobi and Kiambu counties. We also observe that these counties are among the ones 
whose population is suppressed. 
In 2016, the facilities that were sending samples on VL rose to 1868, as compared to 1426 in 
2015. Retention rates in Nyandarua, Kiambu, Migori, Meru and Kirinyaga were highest.This 
means that most of the patients in these counties continued in the treatment in that particular 
year. Population in Counties such as Turkana,Samburu, Mandera,Tana River,Eigeyo Marakwet 
were most suppressed as opposed to people in Kirinyaga, Meru, Migori, Kiambu and Nyandarua 
counties. Lastly, Nairobi, Kisumu, 
Homa Bay, Siaya and Migori had the highest number of persons on 1st Line treatment as well as 
HIV-TB Co-infection. 
In 2017,the total number of facilities that sent the samples was 2122.This was approximately 
13 per cent increase from 2016 and over 170 per cent from 2012. Nyeri, Kiambu, Kirinyaga, 
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Muranga, Kisii had highest retention rates as compared to Elgeyo Marakwet Mandera, Tana River, 
Samburu, Turkana which had least retention rates.Nairobi, Homa Bay, Kisumu Siaya and Migori 
had highest number of people with HIV-TB co-infection as well as patients on 1st Line treatment. 
In terms of suppression, Samburu, Turkana, Tana River, Mandera and Elgeyo Marakwet counties 
are least suppressed. 
High retention did not necessarily mean high suppression rates as will be clearer in the Bayesian 
Approach. 
Below maps show the regions that are least virally suppressed; The areas that had deeper color 
meant that the people in these regions were highly vi rally non-suppressed. 
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Figure 4.7: Map of nonsuppression 2012 
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Figure 4.9: Map of nonsuppression 2014 
Figure 4.11: Map of nonsuppression 2016 
4.2.2 Bayesian Approach 
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Figure 4.1 0: Map of nonsuppression 2015 
Figure 4.12: Map of nonsuppression 2017 
Under Bayesian paradigm, we employed spatial models in order to provide insight of counties 
high non-suppression. This provided a further analysis of predictors of non-suppression. 
Spatial autocorrelation was also measured to assess the extent of the existence of autocorrelation 
in the data using the global Moran's I statistic. The below table shows that the data was spatially 
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autocorrelated owing from the small p values except in 2012, where the p-value was high.Small 
p values show evidence against the null hypodissertation which in this case is that there exists 
no autocorrelation in the data.Existence of spatial autocorrelation meant that counties close to 
each other had almost similar outcomes as compared to those further from each other. Below is 
a summary of the findings; 
Table 4.2: Table Showing a Summary of the Moran's Index from 2012 to 2017 
Year Moran's I standard deviate Moran's I statistics P value Expectation Mean 
2012 0.071422 0.8784906 0.2143 -0.0149 -0.121 
2013 0.081812 0.7062876 0.027 -0.0149 -0.0137 
2014 0.072202 0.8880846 0.0397 -0.0149 -0.0139 
2015 0.082592 0.6158816 0.0524 -0.0149 -0.0158 
2016 0.072982 0.8976786 0.0451 -0.0149 -0.0152 
2017 0.093372 0.7484756 0.0778 -0.0149 -0.0337 
To determine the association of VL suppression and determinants, a Bayesian approach was 
applied where Conditional Autoregressive Model (CAR) was specified. This model depended on 
the conditional distribution of spatial error terms and explained part of the variability of the relative 
risk. 
Prior to modelling, we specified the model using the BUGS (Bayesian inference using Gibbs 
sampler) language, the VL non-suppression data, spatial data describing the neighbourhood 
structure and initial values of the parameters. At analysis stage, MCMC simulation method was 
used and 100,000 iterations specified where the first 10,000 were discarded leaving 90000 and 
each 1 OOth sample was stored. The covariates were included in order to assess and remove the 
effects that occured as a result of confounding factors. 
Further, in Bayesian approach, we modelled expected VL using retention rates, and HIV-TB co-
infections as priors to come up with expected VL. 
In 2012 it shows that counties such as Nyandarua and Kisumu were least suppressed whereas 
counties such as Wajir, West Pokot and Garissa were highly suppressed, but this changes over 
time. 
In 2013 however, we note Homabay is among counties with high viral suppression as well as 
Nandi Counties,however,Busia, Kwale and Kisumu are least virally suppressed.This might be 
due to the fact that they are counties that border Tanzania and Uganda, hence translating to alot 
of movement across the 3 countries leading to little retention and therefore low viral suppression. 
In 2014 this changes. Migori is among the counties that are least vi rally suppressed while other 
counties such as Mandera,Wajir, Garissa and Turkana follow closely after Migori. Counties such 
as lsiolo, Kajiado and Makueni are seen to be doing well in terms of suppression. 
In 2015,most counties are highly suppressed.This might be because of awareness now cre-
ated.However, Nairobi, is still highly non-suppressed still,probably due to the high population in 
the area. 2016, this changes, as Homabay tops up the list of counties that are non-suppressed 
with Garissa and lsiolo following closely behind. 
Lastly, in 2017, still Homabay, Garissa and lsiolo are still among top counties that are least vi rally 
suppressed as well as Kirinyaga, while counties such as kajiado,Kilifi and Lamu are doing much 
better in terms of VL suppression. Below maps show the regions that are least vi rally suppressed; 
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The areas that have deeper color meant that the people in these regions were highly virally 
suppressed • 
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Figure 4.13: Bayesian:non-suppression 2012 Figure 4.14: Bayesian:non-suppression 2013 
Figure 4.15: Bayesian:non-suppression 2014 Figure 4.16: Bayesian :non-suppression 2015 
Figure 4.17: Bayesian:non-suppression 2016 Figure 4.18: Bayesian:non-suppression 2017 
4.3 Discussion 
In this study we have assessed the spatial distribution of VL suppression in Kenya at different 
counties from 2012 to 2017. 
In addition we have identified areas with high VL non-suppression using Bayesian smoothed 
maps, Global Moran's I statistics and the traditional summary statistics approach. 
We also modelled the covariates that had an influence on VL non-suppression. For exploratory 
spatial data analysis, Bayesian smoothed maps of standardized non-VL suppression were gen-
erated. 
Standardized non-VL suppression was modelled to obtain accurate rates, and for comparison. 
This is because, areas with lower population might have indicated high suppression as compared 
to high population areas. This is one weakness of the traditional summary statistics approach we 
used that Bayesian approach covers for. 
This allowed visualization of spatial VL suppression patterns in 47 counties in Kenya. Results 
showed that Homabay, lsiolo and Garissa were least virally suppressed in 2017. In addition most 
of the urban areas have recorded high viral suppression rates, such as Nairobi. Homabay is still 
highly non-suppressed for 2 consecutive years. Homabay's low suppression rates is attributed 
to the fishing that goes on in the area. Mostly, residents in the area engage in sexual activities 
in exchange for fish, a popular delicacy in that area. Other factors may be due to movement of 
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residents from Kenya moving over to Uganda and Tanzania, which may attribute to low retention 
and therefore adherence is poor. Wife inheritance is also a popular culture that has been in place 
since independence. 
Although the practice is getting unpopular, this may be one of the reasons for the low suppression 
rates. Usually, multiple sex partners can contribute to a new HIV strain that may require a different 
HIV regimen altogether. lsiolo and Garissa are popular with the Borana, and Somali and Meru 
people. These groups practice polygamy however, this might not be necessarily a reason for high 
HIV non-suppression rates. Major reason is attributed to literacy levels being low,currently rated 
at 8 per cent by a Kenya National Adult Literacy Survey report that also indicated Nairobi County 
had the highest literacy levels, leading to low and high awareness respectively. 
Global Moran's I for spatial autocorrelation computed showed that counties closer to each other 
had similar relative VL non-suppression as compared to those further away. This relationship is 
significant in 2013 to 2017. We were also able to detect areas of decreasing or increasing trends 
of VL suppression in relationship to their neighbours. 
The Bayesian regression was also fitted to determine predictors of VL Non-suppression. from 
the results the 3 factors HIV!TB co-infection, 1st Line Regimens and retention rates were signifi-
cant. kid is interpreted as p-value. The model has no random effects, no hyperparameters. The 
expected number of effective parameters was (stddev): 13.46(0.00), with number of equivalent 
replicates 113.30, deviance Information Criterion: 354.48, effective number of parameters: 4.973 
and marginallikelihood:-336.0. see table below 
Fixed Effects Mean SD 0.025 quantile 0.5 quantile 0.975 quantile kid 
Intercept 5.12 1.11 2.89 6.44 9.32 0.00011094 
HIV!TB coinfection 21.70 1.55 10.32 23.02 33.34 0.00000980 
1st Line Regimen 23069.04 2133.00 10345.45 23070.36 33415.81 0.00001375 
Retention Rate 46.16 2.54 21.29 47.48 68.78 0.00000746 
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Chapter Five 
Conclusion and Recommendations 
This chapter entails a conclusion on the findings of this dissertation as well as recommendations 
for further research. 
5.1 Conclusion 
Bayesian Models are good because Bayesian inference allows informative priors so that prior 
knowledge or results of a previous model can be used to inform the current modei.Aiso, Bayesian 
inference uses prior distributions, so more information is used and 95 per cent probability in-
tervals of posterior distributions should be narrower than 95 per cent confidence intervals of 
point-estimates. 
Traditional models (whereby non-standardized data is used) are usually easier to prepare be-
cause many things do not need to be specified, such as prior distributions, initial values for 
numerical approximation,and usually the likelihood function unlike in Bayesian approach. 
In this study we found retention as a significant factor and positively affected VL suppression. 
Patients who were retained for a long time were likely to have their VL suppressed.Aithough 
measurement of retention rates has been deemed to be complex, as it involves multiple visits 
over a period of time (Mugavero et al., 2012). 
1st Line ART Regimen and HIV-TB Co-infection go hand in hand as patients who are on 1st Line 
ART regimen are most likely to have TB as well. However, in this study, we identified that these 
two factors were significant variables in determining VL suppression.Co-infections contribute to 
HIV-related pathogenesis and often increase viral load in HIV-infected people (Modjarrad and 
Vermund, 2010), however this is not the case always as HIV patients who have TB but are on 
Anti-TB drugs have been found to have VL below 1 OOOcopies/ml once they started treatment of 
TB. 
5.2 Recommendations for further research 
The work focused only on county level data with the specified variables used to interpret the 
outcome on viral suppression. Spatia-temporal methods could also be used to examine VL sup-
pression data in future studies. Also, viral load suppression can be examined among different de-
mographic groups, as in this research we only focused on county level data only without breaking 
it down into various demographic populations. 
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Kenya<-getData("GADI\!1", country="KE", levei=O) 
Kenya1<-getData("GADII!1", country="KE", level=1) 
Kenya1_LJTMc:-spTransform ( Kenya1 , CAS("+ in i I =EPSG:32737")) 
NAME_1<-Kenya 1_UTM@data$NMAE_1 
Non_Suppression2012 <- c(66.7 ,33.8 ,53.2 ,49.1 ,33.3 ,36.3 ,29.6 ,49.5, 
0.0 ,72.9 ,79.8 ,40.9 ,54.8 ,67.5 ,60.3 ,43.6 ,37.2' 
56.6 ,66.6 ,59.5 ,0.0 ,61. 7 ,60. 7 ,0.0 ,0.0 ,54.4' 
35.9 ,63.3 ,43.0 ,37.9 ,38.0 ,42.2 ,31.1 ,53.2 ,83.5' 
52.8 ,0.0 ,40.8 ,49.3 ,0.0 ,42.0 ,70.2 ,62.2 ,32.5 ,77.4 ,0.0 ,0.0) 
Non_Suppression2013 <- c(59.4 ,44.7 ,41.6 ,31.4 ,39.1 ,65.3 ,59.5 ,45.1, 
73.9 ,46.7 ,69.9 ,52.6 ,35.8 ,44.0 ,42.9 ,47.5 ,30.7' 
58.4 ,57.9 ,47.1 ,33.3 ,61.6 ,55.7 ,0.0 ,51.1 ,65.9 ,50.0' 
47.3 ,53.6 ,35.8 ,54.2 ,40.6 ,32.6 ,74.5 ,64.0 ,47.5 ,0.0' 
44.3 ,57.7 ,38.8 ,53.8 ,34.6 ,62.1 ,33.4 ,66.2 ,0.0 ,32.4) 
Non_Suppression2014 <- c(33. 7 ,32.9, 19.0, 14.0, 30.3 ,33. 7 ,27 .6, 
16.4 ,34.8 ,29.5 '18.9 ,24.9 '15.0 '17.8 '17.2' 
29.5 '15.2 ,30.3 ,8. 7 ,30.3 ,0.0 ,32.9 ,35. 7 ,40. 7' 
35.2 ,26.0 '13.2 ,35.3 ,28.9 '18.8 ,25.5 ,21.5 ,30.9' 
18.3 ,21.2 ,28.3 ,38.3 '19.1 ,24.8 ,27.0 ,39.4 ,21.5' 
50.5 ,23.9 '14.8 ,38.7 ,26.4) 
Non_Suppression2015 <- c(27.8,21.7,18.8,17.0,16.2,16.9,19.6,16.8,19.1, 
19.6 '17.8 ,20.3 '12.9 '18.9' 
13.6 ,22.9 '15.5 '19.4 ,23.1 ' 
16.5 '18.6 '16.9 '17.1 ,41.4 ,21.0' 
13.8 '15.2 '18. 7 '14.5' 
13.5 '18.5 ,21.4 ,25.2 '18.7 '16.0' 
13.6 ,31.9 ,20.7 '19.3' 
27.2,19.5,20.1 ,35.4,21.2,17.2, 
28.6 '19.9) 
Non_Suppression2016 <- c(20.9 ,21.2 ,20.8 ,20.9, 
26.1 '16. 7 '18.6 '15. 7 ,22.3' 
16.8 ,20.3 '17.8 '12.3 '18. 7' 
12.9 '18.8 '15.6 '15.2 ,21.3' 
13.6 ,22.8 '14. 7 '14.0 ,34.3' 
22.5 '12.6 '12.6 '19.3 '14.6' 
15.8 '17. 7 ,22.4 ,22.6 ,20.8' 
12.2 '14.3 ,35.6 ,20.3 '19.3' 
29.3,15.0,23.1 ,36.6,25.5,19.2,19.1 ,23.3) 
Non_Suppression2017 <- c(15.0, 15.0, 14.9 ,20.3, 13.5 ,20.0, 17.7, 15.3, 
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19.5 '11. 7 ,20. 7 '13.1 '16.1 ,23.5 '15.8 '16.2' 
19.0 '18.4 '11.2 '19.5 '11.8 ,23.7 '16.3 '19.6' 
21.5 '11. 7 '19.6 '18.8 '16.9 '19.0 ,21.6 ,38.6' 
15.8 ,21.9 ,20.1 ,22.6 ,24.6 ,28.2 ,20.0 ,26.6' 
41.1 ,25.3 '19.9 ,23.8 ,32.8 ,31. 7 '14.4) 
Non_Suppression2012_df<-data. frame (NAME_1 , Non_Suppression2012) 
Kenya1_UTM@data$id <- rownames(Kenya1_UTM@data) 
Kenya1_UTM@data <- join (Kenya1_UTM@data, Non_Suppression2012_df, 
by= "NAME_1 " ) 
Kenya1_df <- I o rt i I y ( Kenya1_UTM) 
Kenya1_df <- join (Kenya1_df,Kenya1_UTM@data, by="id") 
I i brary (ggmap) 
library(scales) 
theme_opts<-1 i st (theme (panel. grid. minor = element_blank () , 
panel. grid. major = element_blank (), 
panel. background = element_blank () , 
plot. background = element_blank () , 
axis. I i ne = element_blank (), 
ggplot () + 
axis. text. x = element_blank () , 
axis. text. y = element_blank () , 
axis. ticks = element_blank (), 
axis. tit I e . x = element_blank () , 
axis. tit I e . y = element_blank () , 
plot. tit I e = element_blank ())) 
geom_polygon(data = Kenya1_df, aes(x =long, y = lat, group= group, 
I iII = 
Non_Suppression2012), color = "black", size = 0.25) + 
theme(aspect. ratio=1)+ 
scale_lill_distiller(name="Non_Suppression2012", palette= "Reds", trans= "r, 
theme_ void()+ 
labs (tit I e ="o/~Non-Suppressionw for w2012") 
Non_Suppression2013_df<-data. frame (NAME_1 , Non_Suppression2013) 
Kenya1_UTM@data$id <- rownames(Kenya1_UTM@data) 
Kenya1_UTM@data <- join (Kenya1_UTM@data, Non_Suppression2013_df, 
by= "NAME_1 " ) 
Kenya1_df <- I o rt i I y ( Kenya1_UTM) 
Kenya1_df <- join (Kenya1_df,Kenya1_UTM@data, by="id") 
theme_opts<-1 i st (theme (panel. grid. minor = element_blank () , 
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ggplot () + 
panel. grid. major = element_blank (), 
panel. background = element_blank () , 
plot. background = element_blank () , 
axis. I i ne = element_blank (), 
axis. text. x = element_blank () , 
axis. text. y = element_blank () , 
axis. ticks = element_blank (), 
axis. tit I e . x = element_blank () , 
axis. tit I e . y = element_blank () , 
plot. tit I e = element_blank ())) 
geom_polygon(data = Kenya1_df, aes(x =long, y = Ia!, group= group, fill= 
Non_Suppression2013), color = "black", size = 0.25) + 
theme(aspect. ratio=1)+ 
scale_fill_distiller(name="Non_Suppression2013", palette= "Reds", trans= "r, 
theme_ void 0+ 
I abs ( tit I e = "o/~Non--Suppression~ for ~2013") 
Non_Suppression2014_df<-data. frame (NAME_1 , Non_Suppression2014) 
Kenya1_UTM@data$id <- rownames(Kenya1_UTM@data) 
Kenya1_UTM@data <- join (Kenya1_UTM@data, Non_Suppression2014_df, 
by= "NAME_1 " ) 
Kenya1_df <- I o rt i I y ( Kenya1_UTM) 
Kenya1_df <- join (Kenya1_df,Kenya1_UTM@data, by="id") 
theme_opts<-1 i st (theme (panel. grid. minor = element_blank () , 
panel. grid. major = element_blank (), 
panel. background = element_blank () , 
plot. background = element_blank () , 
axis. I i ne = element_blank (), 
ggplot () + 
axis. text. x = element_blank () , 
axis. text. y = element_blank () , 
axis. ticks = element_blank (), 
axis. tit I e . x = element_blank () , 
axis. tit I e . y = element_blank () , 
plot. tit I e = element_blank ())) 
geom_polygon(data = Kenya1_df, aes(x =long, y = lat, group= group, fill= 
Non_Suppression2014), color = "black", size = 0.25) + 
theme(aspect. ratio=1)+ 
scale_fill_distiller(name="Non_Suppression2014", palette= "Reds", trans= "r, 
breaks = pretty _breaks ( n = 5) )+ 
theme_ void 0+ 
I abs ( tit I e = "o/~Non--Suppression~ for ~2014") 
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Non_Suppression2015_df<-data. frame (NAME_1 , Non_Suppression2015) 
Kenya1_UTM@data$id <- rownames(Kenya1_UTM@data) 
Kenya1_UTM@data <- join (Kenya1_UTM@data, Non_Suppression2015_df, by="NAME_1 ") 
Kenya1_df <- I o rt i I y ( Kenya1_UTM) 
Kenya1_df <- join (Kenya1_df,Kenya1_UTM@data, by="id") 
theme_opts<-1 i st (theme (panel. grid. minor = element_blank () , 
panel. grid. major = element_blank (), 
panel. background = element_blank () , 
plot. background = element_blank () , 
axis. I i ne = element_blank (), 
ggplot () + 
axis. text. x = element_blank () , 
axis. text. y = element_blank () , 
axis. ticks = element_blank (), 
axis. tit I e . x = element_blank () , 
axis. tit I e . y = element_blank () , 
plot. tit I e = element_blank ())) 
geom_polygon(data = Kenya1_df, aes(x =long, y = lat, group= group, fill= 
Non_Suppression2015), color = "black", size = 0.25) + 
theme(aspect. ratio=1)+ 
scale_fill_distiller(name="Non_Suppression2015", palette= "Reds", trans= "r, 
theme_ void()+ 
labs ( tit I e ="%""Non-Suppression~ for ~2015") 
Non_Suppression2016_df<-data. frame (NAME_1 , Non_Suppression2016) 
Kenya1_UTM@data$id <- rownames(Kenya1_UTM@data) 
Kenya1_UTM@data <- join (Kenya1_UTM@data, Non_Suppression2016_df, by="NAME_1 ") 
Kenya1_df <- I o rt i I y ( Kenya1_UTM) 
Kenya1_df <- join (Kenya1_df,Kenya1_UTM@data, by="id") 
theme_opts<-1 i st (theme (panel. grid. minor = element_blank () , 
panel. grid. major = element_blank (), 
panel. background = element_blank () , 
plot. background = element_blank () , 
axis. I i ne = element_blank (), 
ggplot () + 
axis. text. x = element_blank () , 
axis. text. y = element_blank () , 
axis. ticks = element_blank (), 
axis. tit I e . x = element_blank () , 
axis. tit I e . y = element_blank () , 
plot. tit I e = element_blank ())) 
geom_polygon(data = Kenya1_df, aes(x =long, y = lat, group= group, fill= 
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Non_Suppression2016), color = "black", size = 0.25) + 
theme(aspect. ratio=1)+ 
scale_fill_distiller(name="Non_Suppression2016", palette= "Reds", trans= "r, 
theme_ void 0+ 
I abs ( tit I e = "o/~Non--Suppression~ for ~2016") 
Non_Suppression2017 _df<-data. frame (NAME_1 , Non_Suppression2017) 
Kenya1_UTM@data$id <- rownames(Kenya1_UTM@data) 
Kenya1_UTM@data <- join (Kenya1_UTM@data, Non_Suppression2017 _df, by="NAME_1 ") 
Kenya1_df <- fortify ( Kenya1_UTM) 
Kenya1_df <- join (Kenya1_df,Kenya1_UTM@data, by="id") 
theme_opts<-1 i st (theme (panel. grid. minor = element_blank 0 , 
panel. grid. major = element_blank 0, 
panel. background = element_blank 0 , 
plot. background = element_blank 0 , 
axis. I i ne = element_blank 0, 
ggplot 0 + 
axis. text. x = element_blank 0 , 
axis. text. y = element_blank 0 , 
axis. ticks = element_blank 0, 
axis. tit I e . x = element_blank 0 , 
axis. tit I e . y = element_blank 0 , 
plot. tit I e = element_blank ())) 
geom_polygon(data = Kenya1_df, aes(x =long, y = Ia!, group= group, fill= 
Non_Suppression2017), color = "black", size = 0.25) + 
theme(aspect. ratio=1)+ 
scale_fill_distiller(name="Non_Suppression2017", palette= "Reds", trans= "r, 
theme_ void 0+ 
I abs ( tit I e = "o/~Non--Suppression~ for ~2017") 
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Bayesian Results 
Table 1· Table Showing Bayesian Anova Results 
ANOVAa,b 
Source Sum of Squares df Mean Square F Sig. 
Regression 54763.759 8 6845.470 65.142 .000 
Residual 28162.726 268 105.085 
Total 82926.486 276 
a. Dependent Variable: Percentage VL Non-suppression 
b. Model: (Intercept), Year, Patientson1stline, HIV-TBCoinfection, Retention-Percent 
Table 2: Table Showing Bayesian Estimates of Coefficients 
Bayesian Estimates of Coefficients a,b,c 
Posterior 95 per cent Credible Interval 
Parameter Mode Mean Variance Lower Bound Upper Bound 
(Intercept) -23.768 -23.768 15.153 -31.403 -16.132 
Year= 2012 42.668 42.668 8.045 37.105 48.231 
Year= 2013 46.104 46.104 8.045 40.540 51.667 
Year= 2014 10.081 10.081 5.862 5.332 14.830 
Year= 2015 7.331 7.331 5.483 2.738 11.924 
Year= 2016 6.230 6.230 5.144 1.781 10.679 
Year= 2017 .d .d .d .d .d 
Patientson1 stline 2.433E-6 2.433E-6 .000 .000 .000 
H IV-TBCoinfection .000 .000 .000 .002 .002 
Retention-Percent .519 .519 .002 .442 .596 
a. Dependent Variable: Percentage VL Non-suppression 
b. Model: (Intercept), Year, Patientson1 stline, HIV-TBCoinfection, Retention-Percent 
c. Assume standard reference priors. 
d. This parameter is redundant. Posterior statistics are not calculated. 
Table 3: Table Showing Bayesian Estimates of Error Variance 
Bayesian Estimates of Error Variance,a 
Posterior 95 per cent Credible Interval 
Parameter Mode Mean Variance Lower Bound Upper Bound 
Error variance 104.306 105.875 84.920 89.337 125.420 
a. Assume standard reference priors 
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Figure 1 : Graph showing likelihood functions for patients 
on 1st Line Regimen 
Patientson1stline 
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Figure 2: Graph showing likelihood functions for HIV-TB 
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- Log Likelihood Function 
- Prior Distribution 
- Posterior Distribution 
Figure 3: Graph showing likelihood functions for Number 
of Patients on Retention 
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